2002
DOI: 10.1021/ol026513n
|View full text |Cite
|
Sign up to set email alerts
|

Angiogenesis Inhibitor Epoxyquinol A:  Total Synthesis and Inhibition of Transcription Factor NF-κB

Abstract: [reaction: see text] The asymmetric synthesis of the natural product (+)-epoxyquinol A (1) and related epoxyquinoid dimers, employing a cascade oxidation/electrocyclization/Diels-Alder dimerization sequence, is reported. In addition, we show that 1 and related molecules inhibit activation of the transcription factor NF-kappaB.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
35
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 70 publications
(35 citation statements)
references
References 19 publications
0
35
0
Order By: Relevance
“…Natural and synthetic epoxyquinoids, such as cycloepoxydon, 84,85 dehydroxymethylepoxyquinomicin (DHMEQ), 86 epoxyquinol A, 87 Figure 4 Structures of SRC2 ((11S)-2a-bromo-3-oxoeudesmano-13,6a-lactone) and peperomins.…”
Section: Epoxyquinoidsmentioning
confidence: 99%
See 3 more Smart Citations
“…Natural and synthetic epoxyquinoids, such as cycloepoxydon, 84,85 dehydroxymethylepoxyquinomicin (DHMEQ), 86 epoxyquinol A, 87 Figure 4 Structures of SRC2 ((11S)-2a-bromo-3-oxoeudesmano-13,6a-lactone) and peperomins.…”
Section: Epoxyquinoidsmentioning
confidence: 99%
“…Chemical biology of inflammatory cytokine signaling T Kataoka epoxyquinol B, 88 epoxyquinone A monomer, 87 jesterone dimer, 89,90 manumycin A 60 and panepoxydone, 91 have been reported to inhibit NF-kB activation. Epoxyquinoids contain the epoxide structure that is known to react with nucleophiles, such as cysteine thiol groups.…”
Section: Epoxyquinoidsmentioning
confidence: 99%
See 2 more Smart Citations
“…[8][9][10][11]. With several electrophilic sites and a high degree of unsaturation, 3 was perceived to be a challenging objective for synthesis, and we elected to explore the possibility of producing this potentially transient intermediate in situ from a doubly activated, polyunsaturated acyclic compound of type 1.…”
mentioning
confidence: 99%